Amine M. Bouchaib is a director of access in Novo Nordisk Canada, overseeing all reimbursement and access related activities, both private and public, for obesity and rare diseases. He holds a master’s degree in corporate finance from Lille 2 University in France and has held several functional roles in various markets in Africa, Europe and Asia during his 15 years in the pharmaceutical industry. Since joining Novo Nordisk Canada in 2020, Bouchaib has been leading and engaged in various initiatives progressing the obesity reimbursement discussions and advancing the overall coverage for obesity treatments in Canada.